Teachers Retirement System of The State of Kentucky Invests $5.87 Million in Humana Inc. (NYSE:HUM)

Teachers Retirement System of The State of Kentucky purchased a new position in shares of Humana Inc. (NYSE:HUM – Get Rating) during the third quarter, HoldingsChannel.com reports. The institutional investor purchased 12,095 shares of the insurance provider’s stock, valued at approximately $5,869,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Atlas Capital Advisors LLC grew its stake in Humana by 546.3% in the 3rd quarter. Atlas Capital Advisors LLC now owns 614 shares of the insurance provider’s stock valued at $298,000 after acquiring an additional 519 shares during the last quarter. MML Investors Services LLC grew its stake in Humana by 7.2% in the 3rd quarter. MML Investors Services LLC now owns 8,003 shares of the insurance provider’s stock valued at $3,883,000 after acquiring an additional 536 shares during the last quarter. Los Angeles Capital Management LLC grew its stake in Humana by 313.5% in the 3rd quarter. Los Angeles Capital Management LLC now owns 62,110 shares of the insurance provider’s stock valued at $30,135,000 after acquiring an additional 47,090 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in Humana by 78.8% in the 3rd quarter. Tower Research Capital LLC TRC now owns 12,670 shares of the insurance provider’s stock valued at $6,148,000 after acquiring an additional 5,583 shares during the last quarter. Finally, Louisiana State Employees Retirement System acquired a new stake in Humana in the 3rd quarter valued at about $3,930,000. 93.38% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Humana

In other Humana news, insider Joseph C. Ventura sold 2,048 shares of the stock in a transaction that occurred on Monday, February 27th. The shares were sold at an average price of $507.97, for a total value of $1,040,322.56. Following the completion of the sale, the insider now owns 4,256 shares of the company’s stock, valued at $2,161,920.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Humana news, Director David A. Jr/Ky Jones sold 15,000 shares of the stock in a transaction that occurred on Wednesday, December 21st. The shares were sold at an average price of $501.72, for a total value of $7,525,800.00. Following the completion of the sale, the director now owns 42,028 shares of the company’s stock, valued at $21,086,288.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Joseph C. Ventura sold 2,048 shares of the stock in a transaction that occurred on Monday, February 27th. The shares were sold at an average price of $507.97, for a total transaction of $1,040,322.56. Following the completion of the sale, the insider now directly owns 4,256 shares of the company’s stock, valued at approximately $2,161,920.32. The disclosure for this sale can be found here. Insiders sold 34,623 shares of company stock valued at $17,456,436 over the last 90 days. 0.39% of the stock is owned by corporate insiders.

Humana Trading Up 0.2 %

NYSE HUM opened at $495.55 on Friday. Humana Inc. has a one year low of $410.87 and a one year high of $571.30. The company’s 50 day moving average price is $494.78 and its 200 day moving average price is $507.39. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.52 and a current ratio of 1.52. The firm has a market capitalization of $61.93 billion, a price-to-earnings ratio of 22.48, a PEG ratio of 1.21 and a beta of 0.72.

Humana (NYSE:HUM – Get Rating) last posted its quarterly earnings results on Wednesday, February 1st. The insurance provider reported $1.62 EPS for the quarter, beating the consensus estimate of $1.46 by $0.16. Humana had a net margin of 3.02% and a return on equity of 20.50%. The firm had revenue of $22.44 billion for the quarter, compared to analyst estimates of $22.45 billion. During the same quarter last year, the firm posted $1.24 earnings per share. Humana’s revenue for the quarter was up 6.6% compared to the same quarter last year. On average, sell-side analysts predict that Humana Inc. will post 28.04 EPS for the current year.

Humana Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, March 31st will be given a $0.885 dividend. This is an increase from Humana’s previous quarterly dividend of $0.79. The ex-dividend date of this dividend is Thursday, March 30th. This represents a $3.54 annualized dividend and a yield of 0.71%. Humana’s dividend payout ratio (DPR) is 14.29%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on HUM. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Humana from $575.00 to $562.00 and set a “buy” rating on the stock in a research note on Tuesday, February 28th. UBS Group reduced their target price on shares of Humana from $645.00 to $620.00 and set a “buy” rating on the stock in a report on Thursday, February 2nd. The Goldman Sachs Group upgraded shares of Humana from a “neutral” rating to a “buy” rating and upped their target price for the company from $575.00 to $652.00 in a report on Tuesday, December 13th. Stephens reduced their target price on shares of Humana from $625.00 to $590.00 and set an “overweight” rating on the stock in a report on Friday, February 3rd. Finally, StockNews.com upgraded shares of Humana from a “buy” rating to a “strong-buy” rating in a report on Wednesday. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $594.12.

About Humana

(Get Rating)

Humana Inc engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts.